¼¼°èÀÇ »ýüÈí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ ¹× ¿¹Ãø - ºê·£µåº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Bioresorbable Coronary Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Brand, By End User, By Region & Competition, 2020-2030F
»óǰÄÚµå : 1703442
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,251,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,641,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,114,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

»ýü Èí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ¼¼°è ½ÃÀåÀº 2024³â 5¾ï 5,009¸¸ ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È Å« ÆøÀ¸·Î ¼ºÀåÇÏ¿© 2030³â±îÁö 10.25%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÃÖ±Ù ½ÉÀ庴ÇÐÀÇ ¹ßÀüÀº °ü»óµ¿¸ÆÁúȯ(CAD) ȯÀÚÀÇ ¿¹ÈÄ¿Í »îÀÇ ÁúÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½Å ¼Ó¿¡¼­ »ýü Èí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ®´Â CAD Ä¡·áÀÇ ÆÐ·¯´ÙÀÓÀ» ¹Ù²Ù´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î µîÀåÇß½À´Ï´Ù. ±âÁ¸ÀÇ ±Ý¼Ó ½ºÅÙÆ®¿Í´Â ´Þ¸®, ÀÌ ½ºÅÙÆ®´Â µ¿¸ÆÀ» ÁöÁöÇÏ´Â ±â´ÉÀ» ¼öÇàÇÑ ÈÄ Ã¼³»¿¡¼­ ¼­¼­È÷ ¿ëÇØµÇµµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 5¾ï 5,009¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 9¾ï 9,008¸¸ ´Þ·¯
CAGR : 2025-2030³â 10.25%
±Þ¼ºÀå ºÎ¹® º´¿ø ¹× Ŭ¸®´Ð
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

½ÉÇ÷°ü Áúȯ(CVDs)ÀÇ À¯º´·ü Áõ°¡

½ÃÀåÀÇ °úÁ¦

È¿°ú¿Í ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á

½ÃÀå µ¿Çâ

±â¼ú ¹ßÀü

¸ñÂ÷

Á¦1Àå Á¦Ç° °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå »ýüÈí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ »ýüÈí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ »ýüÈí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »ýüÈí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ »ýüÈí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ »ýüÈí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ »ýüÈí¼ö¼º °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ȸ»ç ¼Ò°³ ¹× ¸éÃ¥Á¶Ç×

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Bioresorbable Coronary Stents Market was valued at USD 550.09 million in 2024 and is projected to witness substantial growth during the forecast period, registering a CAGR of 10.25% through 2030. Recent advancements in cardiology have significantly enhanced patient outcomes and quality of life for individuals suffering from coronary artery disease (CAD). Among these innovations, bioresorbable coronary stents have emerged as a transformative solution, marking a paradigm shift in CAD treatment. Unlike traditional metallic stents, these stents are designed to gradually dissolve within the body after fulfilling their function of arterial support.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 550.09 Million
Market Size 2030USD 990.08 Million
CAGR 2025-203010.25%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Market Drivers

Increasing Prevalence of Cardiovascular Diseases (CVDs)

The growing global incidence of cardiovascular diseases represents a key driver for market expansion. CVDs remain the leading cause of death globally, responsible for 17.9 million deaths in 2019-approximately 32% of global mortality. Notably, 85% of these fatalities were due to heart attacks and strokes. Furthermore, over 75% of CVD-related deaths occur in low- and middle-income countries, highlighting a critical gap in healthcare infrastructure and access to advanced cardiac care.

The rising number of patients diagnosed with coronary artery disease (CAD) has spurred demand for innovative treatment approaches like bioresorbable coronary stents. In 2022, the global prevalence of CAD was estimated at 315 million cases, with a 95% uncertainty range of 273 to 362 million. The age-standardized prevalence rate was recorded at 3,605 per 100,000 individuals, underscoring the widespread nature of the disease.

The aging global population is a significant contributing factor, as age is the most prominent non-modifiable risk factor for CAD and related cardiovascular conditions. According to the American Heart Association (AHA) 2019 update, 31% of men and 25.4% of women aged 80 and above are diagnosed with CAD. In addition, lifestyle factors such as hypertension, diabetes, obesity, and physical inactivity continue to escalate the global burden of cardiovascular risk, further supporting the shift toward bioresorbable stent adoption.

Market Challenges

Efficacy and Safety Concerns

Despite their promising potential, bioresorbable coronary stents face ongoing scrutiny regarding their clinical safety and efficacy. Some trials have raised concerns about the risk of stent thrombosis-the formation of blood clots within or near the stent-leading to potentially life-threatening complications. These concerns have prompted a comparative evaluation against conventional metallic stents, particularly in terms of long-term safety outcomes.

Market Trends

Technological Advancements

Rapid innovation in medical technology has significantly influenced the development and adoption of bioresorbable coronary stents. Continuous advancements in material science have enabled the creation of stents that maintain mechanical strength during initial healing phases while degrading safely thereafter. The use of biocompatible materials has improved both patient outcomes and procedural safety.

State-of-the-art manufacturing techniques such as 3D printing and laser cutting allow for the production of highly intricate stent designs, optimizing both radial strength and vascular conformability. Many stents are now developed with drug-eluting properties, enabling the controlled release of therapeutic agents to reduce risks of restenosis and inflammation.

Innovations in intravascular imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), have further enhanced procedural accuracy by providing high-resolution, real-time visualization of stent deployment. This precision supports optimal placement and expands the therapeutic potential of bioresorbable stents.

Ongoing clinical research and trials continue to refine stent designs and validate long-term outcomes, offering valuable data that guide next-generation product development and regulatory approvals.

Key Market Players

Report Scope:

In this report, the Global Bioresorbable Coronary Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioresorbable Coronary Stents Market, By Brand:

Bioresorbable Coronary Stents Market, By End User:

Bioresorbable Coronary Stents Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioresorbable Coronary Stents Market.

Available Customizations:

Global Bioresorbable Coronary Stents market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Bioresorbable Coronary Stents Market Outlook

6. North America Bioresorbable Coronary Stents Market Outlook

7. Europe Bioresorbable Coronary Stents Market Outlook

8. Asia-Pacific Bioresorbable Coronary Stents Market Outlook

9. South America Bioresorbable Coronary Stents Market Outlook

10. Middle East and Africa Bioresorbable Coronary Stents Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Bioresorbable Coronary Stents Market: SWOT Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â